Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2021

Ipsen - Spotlight on emerging therapies: Multidisciplinary discussions (advanced RCC, HCC and DTC)

Where are we now? Evolving our strategy in 1L RCC

Date

20 Sep 2021

Session

Ipsen - Spotlight on emerging therapies: Multidisciplinary discussions (advanced RCC, HCC and DTC)

Topics

Tumour Site

Renal Cell Cancer

Presenters

Manuela Schmidinger

Authors

M. Schmidinger

Author affiliations

  • Medicine I, Clinical Division Of Oncology, Vienna General Hospital (AKH) - Medizinische Universität Wien, 1090 - Vienna/AT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and introduction

Presenter: Peter Galle

Session: Ipsen - Spotlight on emerging therapies: Multidisciplinary discussions (advanced RCC, HCC and DTC)

Resources:

Webcast

Thank you and close

Presenter: Peter Galle

Session: Ipsen - Spotlight on emerging therapies: Multidisciplinary discussions (advanced RCC, HCC and DTC)

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.